Indole Derivative Compositions for Drug-Resistant Liver Flukes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for liver fluke infections, particularly those caused by Fasciola hepatica, face challenges due to increasing resistance to existing anthelmintics like triclabendazole, necessitating the development of alternative compounds with low side effects and improved efficacy.
Innovation Solution
The use of indole derivatives in oral, topical, or injectable veterinary compositions that demonstrate anthelmintic effectiveness against trematode infections, including Fasciola hepatica, offering superior efficacy and a quick onset of action with a long duration of activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If triclabendazole is used to treat liver fluke infections, then high efficacy is achieved, but parasite resistance increases
Solution Approach 1:
The patent changes the chemical structure parameter from benzimidazole (triclabendazole) to indole derivatives, creating a new chemical class that bypasses resistance mechanisms developed against triclabendazole while maintaining anthelmintic efficacy against Fasciola hepatica
Solution Approach 2:
The patent combines indole derivatives with macrocyclic lactones to create a composite anthelmintic composition that targets different physiological pathways in the parasite, thereby overcoming resistance to either agent alone
2Reliability
If existing anthelmintics are used, then treatment effectiveness is maintained, but side effects increase
Solution Approach 1:
The patent changes the chemical structure to indole derivatives with modified pharmacological properties that maintain anthelmintic effectiveness while reducing toxic side effects compared to traditional benzimidazoles and halogenated compounds
3Speed
If faster acting treatments are used, then speed of onset is improved, but duration of activity may be reduced
Solution Approach 1:
The patent designs indole derivative compositions that provide continuous anthelmintic action through sustained release mechanisms and combination with macrocyclic lactones, ensuring both rapid initial effect and prolonged duration of activity
Data Source
AI summary
The invention relates to oral, topical or injectable compositions for combating liver fluke parasites in mammals, comprising at least one indole derivative active agent. The invention also provides for an improved method for eradicating and controlling liver fluke parasite infections and infestations in a mammal comprising administering the compositions of the invention to the mammal in need thereof.


